Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent [gamma]-secretase inhibitors

The structure-activity relationship (SAR) of a novel, potent and metabolically stable series of sulfonamide-pyrazoles that attenuate [beta]-amyloid peptide synthesis via [gamma]-secretase inhibition is detailed herein. Sulfonamide-pyrazoles that are efficacious in reducing the cortical A[beta]x-40 l...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 21; no. 19; pp. 5791 - 5794
Main Authors Aubele, Danielle L, Truong, Anh P, Dressen, Darren B, Probst, Gary D, Bowers, Simeon, Mattson, Matthew N, Semko, Chris M, Sun, Minghua, Garofalo, Albert W, Konradi, Andrei W, Sham, Hing L, Zmolek, Wes, Wong, Karina, Goldbach, Erich, Quinn, Kevin P, Sauer, John-Michael, Brigham, Elizabeth F, Wallace, William, Nguyen, Lan, Bova, Michael P, Hemphill, Susanna S, Basi, Guriqbal
Format Journal Article
LanguageEnglish
Published 01.10.2011
Online AccessGet full text

Cover

More Information
Summary:The structure-activity relationship (SAR) of a novel, potent and metabolically stable series of sulfonamide-pyrazoles that attenuate [beta]-amyloid peptide synthesis via [gamma]-secretase inhibition is detailed herein. Sulfonamide-pyrazoles that are efficacious in reducing the cortical A[beta]x-40 levels in FVB mice via a single PO dose, as well as sulfonamide-pyrazoles that exhibit selectivity for inhibition of APP versus Notch processing by [gamma]-secretase, are highlighted.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-1
ISSN:0960-894X
DOI:10.1016/j.bmcl.2011.08.008